Randox Research offers a comprehensive range of technologies and solutions to make oncology focused research become more efficient, cost effective and accurate. The Randox research division has over 70 oncology biomarkers that can be custom picked to be assayed on the award winning multiplexing Biochip Array Technology.

Simply choose relevant biomarkers from our extensive list and we’ll create your ideal multiplex array, choose from markers of inflammation, angiogenesis biomarkers, cell signalling markers, molecular markers of drug efficacy.

Randox also offers a rapid multiplex PCR array, which identifies 20 major mutations across the KRAS, BRAF and PIK3CA genes.

Click through our interactive infographic for more information